Amedisys Inc
(STU:ADY)
€
87
0 (0%)
Market Cap: 2.90 Bil
Enterprise Value: 3.24 Bil
PE Ratio: 0
PB Ratio: 2.87
GF Score: 85/100 Amedisys Inc at UBS Global Healthcare Conference (Virtual) Transcript
May 18, 2020 / 07:00PM GMT
Release Date Price:
€179
(+7.19%)
Benjamin Whitman Mayo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare Facilities and Managed Care
Great. Let's go ahead and get started. Sorry for the delay. We were having a little dial-in issue on our end. But it's my pleasure to have the team from Amedisys. Not exactly sure who all is on the line. I think, Paul, Nick, maybe Chris. So I don't know who -- you want to give a quick introduction, Paul?
Paul Berthold Kusserow
Amedisys, Inc. - Chairman, President & CEO
Yes. Whit, Paul Kusserow here, CEO. We've got Chris Gerard, COO; Scott Ginn, CFO; and Nick Muscato. That's everything...
Benjamin Whitman Mayo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare Facilities and Managed Care
Whole team.
Paul Berthold Kusserow
Amedisys, Inc. - Chairman, President & CEO
Yes.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot